The blockchain-based lending platform beat revenue estimates but fell short on earnings, even as annual profit reached $134 million.Shares of Figure Technology The blockchain-based lending platform beat revenue estimates but fell short on earnings, even as annual profit reached $134 million.Shares of Figure Technology

Figure Technology stock crashes 20% following mixed Q4 earnings

2026/02/28 01:44
1 min read

The blockchain-based lending platform beat revenue estimates but fell short on earnings, even as annual profit reached $134 million.

Shares of Figure Technology Solutions, a blockchain-based consumer lending marketplace, plunged on Friday after the company reported mixed fourth-quarter results the prior day, signaling a more difficult operating environment even as revenue continued to climb.

Figure Technology stock crashes 20% following mixed Q4 earnings

For the quarter ended Dec. 31, the company posted revenue of $159.9 million, up from $83.9 million a year earlier, and net income of $15.1 million, compared with $5.9 million in the same period of 2024. Earnings were $0.06 per diluted share, compared to zero a year earlier.

Analysts polled by Yahoo Finance expected earnings of $0.18 per share on revenue of $157.7 million.

Read more

Market Opportunity
Ucan fix life in1day Logo
Ucan fix life in1day Price(1)
$0.0005494
$0.0005494$0.0005494
-7.50%
USD
Ucan fix life in1day (1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.